Literature DB >> 31240834

Anthropometrics, diet, and resting energy expenditure in Norwegian adults with achondroplasia.

Andrea Madsen1, Svein O Fredwall2,3, Grethe Maanum4, Christine Henriksen1, Hanne B Slettahjell4.   

Abstract

Individuals with achondroplasia have a high prevalence of obesity and increased risk of cardiovascular disease. Fat distribution, diet, and caloric intake are known risk factors, but the literature concerning diet and energy balance in achondroplasia is limited. The main aim of this study was to describe the anthropometrics, diet, and resting energy expenditure (REE) in a Norwegian adult achondroplasia population. Here, we present a descriptive cross-sectional study with the following variables: anthropometrics, the SmartDiet questionnaire, and dietary records. In addition, REE was measured and estimated using indirect calorimetry and prediction equations. A total of 33 adults with achondroplasia participated with a mean age of 40 years. Mean body mass index was 34.1 kg/m2 , and mean waist circumference was 94.1 cm for men and 82.2 cm for women. Their diets were classified as unhealthy (38%) or in need of improvement (62%). The mean REE values for the total group were 21 kcal/kg for the male (n = 15) and 20 kcal/kg for the female (n = 18). This study revealed a high frequency of central obesity and unhealthy dietary habits in Norwegian adults with achondroplasia. Mean energy intake was low and only 10% higher than the mean REE, and does not explain the high prevalence of abdominal obesity in our population.
© 2019 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals, Inc.

Entities:  

Keywords:  achondroplasia; body composition; body mass index; diet; resting energy expenditure; waist circumference

Year:  2019        PMID: 31240834     DOI: 10.1002/ajmg.a.61272

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

Review 1.  International Consensus Statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia.

Authors:  Ravi Savarirayan; Penny Ireland; Melita Irving; Dominic Thompson; Inês Alves; Wagner A R Baratela; James Betts; Michael B Bober; Silvio Boero; Jenna Briddell; Jeffrey Campbell; Philippe M Campeau; Patricia Carl-Innig; Moira S Cheung; Martyn Cobourne; Valérie Cormier-Daire; Muriel Deladure-Molla; Mariana Del Pino; Heather Elphick; Virginia Fano; Brigitte Fauroux; Jonathan Gibbins; Mari L Groves; Lars Hagenäs; Therese Hannon; Julie Hoover-Fong; Morrys Kaisermann; Antonio Leiva-Gea; Juan Llerena; William Mackenzie; Kenneth Martin; Fabio Mazzoleni; Sharon McDonnell; Maria Costanza Meazzini; Josef Milerad; Klaus Mohnike; Geert R Mortier; Amaka Offiah; Keiichi Ozono; John A Phillips; Steven Powell; Yosha Prasad; Cathleen Raggio; Pablo Rosselli; Judith Rossiter; Angelo Selicorni; Marco Sessa; Mary Theroux; Matthew Thomas; Laura Trespedi; David Tunkel; Colin Wallis; Michael Wright; Natsuo Yasui; Svein Otto Fredwall
Journal:  Nat Rev Endocrinol       Date:  2021-11-26       Impact factor: 47.564

Review 2.  Obesity in achondroplasia patients: from evidence to medical monitoring.

Authors:  Celine Saint-Laurent; Laura Garde-Etayo; Elvire Gouze
Journal:  Orphanet J Rare Dis       Date:  2019-11-14       Impact factor: 4.123

3.  Pharmacokinetics and Exposure-Response of Vosoritide in Children with Achondroplasia.

Authors:  Ming Liang Chan; Yulan Qi; Kevin Larimore; Anu Cherukuri; Lori Seid; Kala Jayaram; George Jeha; Elena Fisheleva; Jonathan Day; Alice Huntsman-Labed; Ravi Savarirayan; Melita Irving; Carlos A Bacino; Julie Hoover-Fong; Keiichi Ozono; Klaus Mohnike; William R Wilcox; William A Horton; Joshua Henshaw
Journal:  Clin Pharmacokinet       Date:  2021-08-25       Impact factor: 6.447

4.  Achondroplasia Natural History Study (CLARITY): a multicenter retrospective cohort study of achondroplasia in the United States.

Authors:  Julie E Hoover-Fong; Adekemi Y Alade; S Shahrukh Hashmi; Jacqueline T Hecht; Janet M Legare; Mary Ellen Little; Chengxin Liu; John McGready; Peggy Modaff; Richard M Pauli; David F Rodriguez-Buritica; Kerry J Schulze; Maria Elena Serna; Cory J Smid; Michael B Bober
Journal:  Genet Med       Date:  2021-05-18       Impact factor: 8.822

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.